Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

MLA

Rosas, Ivan O., et al. “Tocilizumab and Remdesivir in Hospitalized Patients with Severe COVID-19 Pneumonia: A Randomized Clinical Trial.” Intensive Care Medicine, vol. 47, no. 11, Nov. 2021, p. 1258. EBSCOhost, https://doi.org/10.1007/s00134-021-06507-x.

APA

Rosas, I. O., Diaz, G., Gottlieb, R. L., Lobo, S. M., Robinson, P., Hunter, B. D., & Cavalcante, A. W. (2021). Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial. Intensive Care Medicine, 47(11), 1258. https://doi.org/10.1007/s00134-021-06507-x

Chicago

Rosas, Ivan O., George Diaz, Robert L. Gottlieb, Suzana M. Lobo, Philip Robinson, Bradley D. Hunter, and Adilson W. Cavalcante. 2021. “Tocilizumab and Remdesivir in Hospitalized Patients with Severe COVID-19 Pneumonia: A Randomized Clinical Trial.” Intensive Care Medicine 47 (11): 1258. doi:10.1007/s00134-021-06507-x.